Stock & Company Details
Imunon Inc $IMNN
Price:
N/A
N/A
5.6M
$21M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.15
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IMNN technical indicators
Latest Imunon Inc (IMNN) indicator readings as of 2026-10-29.
IMNN's 14-day RSI is 29.2, in oversold territory. At $0.83 it is trading 63.0% below its 200-day moving average of $2.25, and below its 50-day average of $1.33. Price sits near the lower Bollinger Band ($0.82 to $1.34). ADX reads 27.4, indicating a trending market.
Overview
Celsion is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company's product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox®, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection.
Finance Bot
Ask your questions
Start by typing a question below.
